Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming

June 23, 2026 4:36 AM

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $63.00 price target on Sionna Therapeutics (NASDAQ: SION).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found